Novo Nordisk prepares to go global as triple-G prospect passes midphase diabetes test in China Read more →
BrightGene's oral dual agonist sees up to 8% weight loss at 8 weeks in slice of early data Read more →
Icon, Advarra partnership aims to optimize trials, expand access Read more →
Max Eldridge
Max has more than ten years in Life Sciences recruitment, He collaborates with executives to foster growth in Pharma, Biotech, CRO, TechBio, and Medical Device sectors